AZILSARTAN AS A POTENT ANTIHYPERTENSIVE DRUG WITH POSSIBLE PLEIOTROPIC CARDIOMETABOLIC EFFECTS: A REVIEW STUDY.

Background: Hypertension related cardiovascular (CV) complications could be amplified by the presence of metabolic co-morbidities. Azilsartan medoxomil (AZL-M) is the eighth approved member of angiotensin II receptor blockers (ARBs), a drug class of high priority in the management of hypertensive su...

Full description

Bibliographic Details
Published in:	Frontiers in Pharmacology
Main Authors:	Georgiopoulos Georgios, Vasiliki Katsi, Dimitrios Oikonomou, Georgia Vamvakou, Evangelia Koutli, Aggeliki Laina, Constantinos Tsioufis, Petros Nihoyannopoulos, Dimitrios Tousoulis
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-08-01
Subjects:	Diabetes Mellitus Hypertension cardiovascular metabolic Azilsartan medoxomil Pleiotropic
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00235/full

Similar Items

Looking for an optimal antihypertensive combination. Focus on azilsartan medoxomil/chlorthalidone
by: M. D. Smirnova, et al.
Published: (2025-01-01)

MODERN OPPORTUNITIES FOR ANTIHYPERTENSION THERAPY: THE PLACE OF AZILSARTAN MEDOXOMIL
by: V. V. Skibitsky, et al.
Published: (2017-12-01)

Comparative analysis of antihypertensive effects of chlorthalidone and indapamide-retard in combination with azilsartan medoxomil in patients with arterial hypertension
by: Zh. D. Kobalava, et al.
Published: (2019-07-01)

Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
by: Attila Juhasz, et al.
Published: (2018-02-01)

Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis
by: Ling Zhu, et al.
Published: (2024-07-01)

Central Composite Design Implemented Azilsartan Medoxomil Loaded Nanoemulsion to Improve Its Aqueous Solubility and Intestinal Permeability: In Vitro and Ex Vivo Evaluation
by: Girish Kumar, et al.
Published: (2022-10-01)

Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes
by: A. M. Kochergina, et al.
Published: (2023-11-01)

EFFICACY OF AZILSARTAN MEDOXOMIL ON THE DAILY PROFILE OF PERIPHERAL AND CENTRAL ARTERIAL PRESSURE AND ARTERIAL STIFFNESS IN HYPERTENSIVES WITH TYPE 2 DIABETES
by: E. A. Troitskaya, et al.
Published: (2017-02-01)

Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review
by: Vadim D. Zakiev, et al.
Published: (2023-11-01)

Possible combined effect of perindopril and Azilsartan in an experimental model of dementia in rats
by: Yahya M. Alzahrani, et al.
Published: (2020-05-01)

Comparative Efficacy of Single Pill Combinations of Azilsartan Medoxomil/Chlorthalidone and Losartan/Hydrochlorothiazide in Patients with Hypertension and Heart Failure with Preserved Ejection Fraction
by: Zh. D. Kobalava, et al.
Published: (2022-05-01)

UPLC–MS/MS for the determination of azilsartan in beagle dog plasma and its application in a pharmacokinetics study
by: Cheng Gong, et al.
Published: (2015-06-01)

Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial
by: Takaichi Suehiro, et al.
Published: (2021-03-01)

Optimization, characterization and in vitro/vivo evaluation of azilsartan nanocrystals
by: Jingjing Ma, et al.
Published: (2017-07-01)

Isolation and structural elucidation of novel degradant during degradation study of Azilsartan kamedoxomil
by: Anil Kumar Guduri, et al.
Published: (2024-12-01)

Synthesis of Two Novel Azilsartan Cocrystals: Preparation, Physicochemical Characterization and Solubility Studies
by: Lei Gao, et al.
Published: (2020-08-01)

The Possible Hepatoprotective Effects of Azilsartan against Carbon Tetrachloride CCl4 - Induced Liver Fibrosis in Male Rats in Comparison with Silymarin: ''in vivo Study''
by: Mohammed Jasim Mohammed, et al.
Published: (2025-09-01)

Gastroprotective Effect of Azilsartan Through Ameliorating Oxidative Stress, Inflammation, and Restoring Hydroxyproline, and Gastrin Levels in Ethanol-Induced Gastric Ulcer
by: Hama Amin RR, et al.
Published: (2022-05-01)

Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
by: M. G. Bubnova
Published: (2008-12-01)

EVALUATION OF ANTIHYPERTENSIVE THERAPY WITH THE COMBINATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
by: Steven G. Chrysant, et al.
Published: (2011-06-01)

Dipping pattern of nocturnal blood pressure in hypertensive patients treated with azilsartan
by: P. L. N. Kapardhi, et al.
Published: (2020-01-01)

Azilsartan medoxomil for improving insulin resistance and adipokine levels in hypertension in comparison with angiotensin-converting enzyme inhibitors
by: S. V. Nedogoda, et al.
Published: (2020-08-01)

Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis in vivo via suppression of TNF-α expression in macrophages
by: Ziqiu Fan, et al.
Published: (2023-09-01)

Pleiotropic effects of statins
by: Narasaraju Kavalipati, et al.
Published: (2015-01-01)

Conceptual Framework of the Design of Pleiotropic Drugs against Alzheimer’s Disease
by: Thomas Guiselin, et al.
Published: (2023-09-01)

Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon?
by: I. A. Latfullin, et al.
Published: (2015-12-01)

Implication of endoplasmic reticulum stress and mitochondrial perturbations in remote liver injury after renal ischemia/reperfusion in rats: potential protective role of azilsartan
by: Rania A. Elrashidy, et al.
Published: (2024-12-01)

Azilsartan Modulates HMGB1/NF-κB/p38/ERK1/2/JNK and Apoptosis Pathways during Renal Ischemia Reperfusion Injury
by: Rania Alaaeldin, et al.
Published: (2023-01-01)

Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan
by: Rania Alaaeldin, et al.
Published: (2022-11-01)

PLEIOTROPIC EFFECTS OF VITAMIN D
by: O. M. Drapkina, et al.
Published: (2016-05-01)

Lipid lowering and additional pleiotropic effects of statins
by: Ali Çoner, et al.
Published: (2025-04-01)

Effects of two different angiotensin receptor blockers on blood glucose level and HbA1c in type-2 diabetes mellitus patients with hypertension
by: Shafat Iqbal Bhati, et al.
Published: (2023-10-01)

Dimethyl sulfoxide: a substance with pleiotropic effects actual in musculoskeletal diseases
by: D. Yu. Ivkin, et al.
Published: (2021-06-01)

Arterial Hypertension and Health-Related Quality of Life
by: Vasiliki Katsi, et al.
Published: (2017-12-01)

Comparative analysis of cardiovascular system morphofunctional disorders’ correction in a simulated metabolic syndrome
by: Cyril O. Tarimov, et al.
Published: (2020-09-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

ANTIATHEROGENIC AND PLEIOTROPIC ACTIVITY OF VARIOUS DOSES OF ATORVASTATIN IN PATIENTS WITH ISCHEMIC STROKE
by: M. G. Bubnova, et al.
Published: (2013-08-01)

Development and Evaluation of a Modified Fixed-Dose Combination Antihypertensive Tablet Containing S-Amlodipine Besylate: A Bioequivalence and Stability Study
by: Hyeon Woo Moon, et al.
Published: (2025-09-01)

PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY
by: I. V. Shirinsky, et al.
Published: (2019-01-01)

Echocardiography and cardiac arrhythmias
by: Constantinos H. Papadopoulos, et al.
Published: (2018-05-01)